Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Rapid Dose Therapeutics Corp (RDTCF) AI Stock Analysis

0 Followers
RDTCF

Rapid Dose Therapeutics Corp

(Other OTC:RDTCF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Improved Cash GenerationTTM operating and free cash flow of about $0.42M indicates a recent improvement in cash conversion and financial discipline. If maintained, this could help fund operations without immediate external capital, although durability depends on working-capital and spending patterns.
Negative Factors
Declining RevenueRevenue contraction indicates that recent commercial momentum has weakened after several years of growth from a small base. A smaller revenue platform makes it harder to absorb fixed costs, fund development, and demonstrate that the QuickStrip model can scale sustainably.

Rapid Dose Therapeutics Corp (RDTCF) vs. SPDR S&P 500 ETF (SPY)

-100%-75%-50%-25%0%25%RDTCF-62.00%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$13.78M
Dividend Yield
―
Average Volume (3M)
23.79K
Price to Earnings (P/E)
-4.3
Beta (1Y)
0.25
Revenue Growth
-18.50%
EPS Growth
34.12%
Country
US
Employees
12
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Rapid Dose Therapeutics Corp Business Overview & Revenue Model

Company Description

Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship p...

Rapid Dose Therapeutics Corp Peers Comparison

Overall Rating

Financial Indicators

RDTCF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-80%-60%-40%-20%0%RDTCFDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
RDTCF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
RDTCFRapid Dose Therapeutics Corp0.06-0.09-62.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.